Literature DB >> 22156847

What is the impact of home-based HIV counseling and testing on the clinical status of newly enrolled adults in a large HIV care program in Western Kenya?

Juddy Wachira1, Sylvester Kimaiyo, Samson Ndege, Joseph Mamlin, Paula Braitstein.   

Abstract

BACKGROUND: This article describes the effect point of entry into the human immunodeficiency virus (HIV) care program had on the clinical status of adults presenting for the first time to USAID-AMPATH (US Agency for International Development-Academic Model Providing Access to Healthcare) Partnership clinics for HIV care.
METHODS: All patients aged ≥ 14 years enrolled between August 2008 and April 2010 were included. Points of entry to USAID-AMPATH clinics were home-based counseling and testing (HBCT), provider-initiated testing and counseling (PITC), HIV testing in the tuberculosis clinic, and voluntary counseling and testing (VCT). Tests for trend were calculated, and multivariable logistic regression was used to compare the effect of HBCT versus other points of entry on primary outcomes controlling for age and sex.
RESULTS: There were 19,552 eligible individuals. Of these, 946 tested in HBCT, 10,261 in VCT, 8073 in PITC, and 272 in the tuberculosis clinic. The median (interquartile range) enrollment CD4 cell counts among those who tested HIV positive was 323 (194-491), 217 (87-404), 190 (70-371), and 136 cells/mm(3) (59-266) for HBCT, VCT, PITC, and the tuberculosis clinic, respectively (P < .001). Compared with those patients whose HIV infection was diagnosed in the tuberculosis clinic, those who tested positive in HBCT were, controlling for age and sex, less likely to have to have World Health Organization stage III or IV HIV infection at enrollment (adjusted odds ratio [AOR], 0.04; 95% confidence interval [CI], .03-.06), less likely to enroll with a CD4 cell count of <200 cells/mm(3) (AOR, 0.20; 95% CI, .14-.28), and less likely to enroll into care with a chief complaint (AOR, 0.08; 95% CI, .05-.12).
CONCLUSIONS: HBCT is effective at getting HIV-infected persons enrolled in HIV care before they become ill.

Entities:  

Mesh:

Year:  2011        PMID: 22156847     DOI: 10.1093/cid/cir789

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  51 in total

1.  Linkage to and engagement in HIV care in western Kenya: an observational study using population-based estimates from home-based counselling and testing.

Authors:  Becky L Genberg; Violet Naanyu; Juddy Wachira; Joseph W Hogan; Edwin Sang; Monicah Nyambura; Michael Odawa; Corey Duefield; Samson Ndege; Paula Braitstein
Journal:  Lancet HIV       Date:  2015-01       Impact factor: 12.767

2.  Addressing the Achilles' heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation.

Authors:  Jean B Nachega; Olalekan A Uthman; Carlos del Rio; Michael J Mugavero; Helen Rees; Edward J Mills
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

3.  A home tracing program for contacts of people with tuberculosis or HIV and patients lost to care.

Authors:  C B Deery; C F Hanrahan; K Selibas; J Bassett; I Sanne; A Van Rie
Journal:  Int J Tuberc Lung Dis       Date:  2014-05       Impact factor: 2.373

4.  Trends Over Time for Adolescents Enrolling in HIV Care in Kenya, Tanzania, and Uganda From 2001-2014.

Authors:  Edith Apondi; John M Humphrey; Edwin Sang; Ann Mwangi; Alfred Keter; Beverly S Musick; Fred K Nalugoda; John Ssali; Elizabeth Bukusi; Constantin T Yiannoutsos; Kara Wools-Kaloustian; Samuel Ayaya
Journal:  J Acquir Immune Defic Syndr       Date:  2018-10-01       Impact factor: 3.731

5.  Geography should not be destiny: focusing HIV/AIDS implementation research and programs on microepidemics in US neighborhoods.

Authors:  Amy Nunn; Annajane Yolken; Blayne Cutler; Stacey Trooskin; Phill Wilson; Susan Little; Kenneth Mayer
Journal:  Am J Public Health       Date:  2014-05       Impact factor: 9.308

6.  Health care utilization and access to human immunodeficiency virus (HIV) testing and care and treatment services in a rural area with high HIV prevalence, Nyanza Province, Kenya, 2007.

Authors:  Marta-Louise Ackers; Allen Hightower; David Obor; Peter Ofware; Lilian Ngere; Adazu Kubaje; Kayla F Laserson
Journal:  Am J Trop Med Hyg       Date:  2013-12-09       Impact factor: 2.345

Review 7.  Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects.

Authors:  Larry W Chang; David Serwadda; Thomas C Quinn; Maria J Wawer; Ronald H Gray; Steven J Reynolds
Journal:  Lancet Infect Dis       Date:  2013-01       Impact factor: 25.071

8.  HIV testing: current practice and future directions.

Authors:  Peter Cherutich; Rebecca Bunnell; Jonathan Mermin
Journal:  Curr HIV/AIDS Rep       Date:  2013-06       Impact factor: 5.071

9.  High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa.

Authors:  Heidi van Rooyen; Ruanne V Barnabas; Jared M Baeten; Zipho Phakathi; Philip Joseph; Meighan Krows; Ting Hong; Pamela M Murnane; James Hughes; Connie Celum
Journal:  J Acquir Immune Defic Syndr       Date:  2013-09-01       Impact factor: 3.731

Review 10.  Beyond early infant diagnosis: case finding strategies for identification of HIV-infected infants and children.

Authors:  Saeed Ahmed; Maria H Kim; Nandita Sugandhi; B Ryan Phelps; Rachael Sabelli; Mamadou O Diallo; Paul Young; Dana Duncan; Scott E Kellerman
Journal:  AIDS       Date:  2013-11       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.